Page last updated: 2024-08-23

pirfenidone and Sensitivity and Specificity

pirfenidone has been researched along with Sensitivity and Specificity in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (50.00)	29.6817
2010's	4 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J	1
Bradford, WZ; Fagan, EA; Glaspole, I; Glassberg, MK; Glasscock, KF; Kardatzke, D; King, TE; Lancaster, LH; Lederer, DJ; Nathan, SD; Noble, PW; Pereira, CA; Sahn, SA; Swigris, JJ	1
Abrenica, B; Bagchi, RA; Czubryt, MP; Mozolevska, V	1
Crestani, B; Porcher, R; Richeldi, L; Thabut, G	1
Baba, T; Gotoh, T; Inoue, T; Iwasawa, T; Kanauchi, T; Komagata, T; Morita, S; Ogura, T; Sakai, F; Yazawa, T	1
Abe, K; Fujii, T; Hayashi, T; Ishii, H; Kadota, J; Kakugawa, T; Kohno, S; Miyazaki, M; Mukae, H; Oku, H	1
Forslund, T; Iversen, BM; Leh, S; Margolin, SB; Vaagnes, Ø	1
Chen, Y; Liu, X; Wang, G; Wang, Y; Zhao, X; Zhong, J	1

Trials

2 trial(s) available for pirfenidone and Sensitivity and Specificity

Article	Year
Sensitivity Analyses of the Change in FVC in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary Fibrosis. Chest, 2015, Volume: 148, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Idiopathic Pulmonary Fibrosis; Male; Middle Aged; Pyridones; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Vital Capacity	2015
CT analysis of the effect of pirfenidone in patients with idiopathic pulmonary fibrosis. European journal of radiology, 2014, Volume: 83, Issue:1 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Idiopathic Pulmonary Fibrosis; Lung; Male; Pyridones; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome	2014

Article

Year

Sensitivity Analyses of the Change in FVC in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary Fibrosis.

Chest, 2015, Volume: 148, Issue:1

Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Idiopathic Pulmonary Fibrosis; Male; Middle Aged; Pyridones; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Vital Capacity

2015

CT analysis of the effect of pirfenidone in patients with idiopathic pulmonary fibrosis.

European journal of radiology, 2014, Volume: 83, Issue:1

Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Idiopathic Pulmonary Fibrosis; Lung; Male; Pyridones; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome

2014

Other Studies

6 other study(ies) available for pirfenidone and Sensitivity and Specificity

Article	Year
Chemical genetics reveals a complex functional ground state of neural stem cells. Nature chemical biology, 2007, Volume: 3, Issue:5 Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells	2007
Development of a high throughput luciferase reporter gene system for screening activators and repressors of human collagen Iα2 gene expression. Canadian journal of physiology and pharmacology, 2015, Volume: 93, Issue:10 Topics: Angiotensin II; Animals; Cloning, Molecular; Collagen Type I; Connective Tissue Growth Factor; Fibroblasts; Gene Expression; Genes, Reporter; High-Throughput Screening Assays; Humans; Luciferases; Mice; NIH 3T3 Cells; Pyridones; Sensitivity and Specificity; Transcription, Genetic; Transfection; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha	2015
Missing data in IPF trials: do not let methodological issues undermine a major therapeutic breakthrough. The European respiratory journal, 2015, Volume: 46, Issue:3 Topics: Clinical Trials, Phase III as Topic; Data Collection; Data Interpretation, Statistical; Female; Humans; Idiopathic Pulmonary Fibrosis; Indoles; Male; Pyridones; Randomized Controlled Trials as Topic; Respiratory Function Tests; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Survival Rate; Treatment Outcome; Vital Capacity	2015
Pirfenidone attenuates expression of HSP47 in murine bleomycin-induced pulmonary fibrosis. The European respiratory journal, 2004, Volume: 24, Issue:1 Topics: Analysis of Variance; Animals; Biopsy, Needle; Bleomycin; Disease Models, Animal; HSP70 Heat-Shock Proteins; Hydroxyproline; Immunohistochemistry; Injections, Intravenous; Male; Mice; Mice, Inbred Strains; Probability; Pulmonary Fibrosis; Pyridones; Random Allocation; Reference Values; Sensitivity and Specificity	2004
Pirfenidone and candesartan ameliorate morphological damage in mild chronic anti-GBM nephritis in rats. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2005, Volume: 20, Issue:1 Topics: Analysis of Variance; Animals; Antibodies; Autoantibodies; Base Sequence; Benzimidazoles; Biopsy, Needle; Biphenyl Compounds; Blood Chemical Analysis; Blood Pressure Determination; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Glomerulonephritis; Immunohistochemistry; Kidney Function Tests; Male; Molecular Sequence Data; Probability; Pyridones; Random Allocation; Rats; Rats, Wistar; Reference Values; Renal Circulation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sensitivity and Specificity; Statistics, Nonparametric; Tetrazoles	2005
Simple determination of pirfenidone in rat plasma via high-performance liquid chromatography. Biomedical chromatography : BMC, 2006, Volume: 20, Issue:12 Topics: Animals; Chromatography, High Pressure Liquid; Drug Stability; Pyridones; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity	2006